DOI:
10.1055/s-00034925
Hämostaseologie
LinksClose Window
References
Coppo P, Bubenheim M, Azoulay E. et al.
A regimen with caplacizumab, immunosuppression and plasma exchange prevents unfavorable outcomes in immune-mediated TTP.
Blood 2020; blood.2020008021
Search in:
We do not assume any responsibility for the contents of the web pages of other providers.